These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 3917454

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Plasma growth hormone (GH) responses to single and repetitive subcutaneous administration of GH releasing factor (hpGRF-44) in normal and GH deficient children.
    Takano K, Hizuka N, Shizume K, Honda N, Ling NC.
    Acta Endocrinol (Copenh); 1985 Jan; 108(1):11-9. PubMed ID: 3918397
    [Abstract] [Full Text] [Related]

  • 25. Growth hormone release in response to human pancreatic tumor growth hormone-releasing hormone-40 in children with short stature.
    Rogol AD, Blizzard RM, Johanson AJ, Furlanetto RW, Evans WS, Rivier J, Vale WW, Thorner MO.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):580-6. PubMed ID: 6434572
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Pulsatile growth hormone secretion in patients with acromegaly and normal men: the effects of growth hormone-releasing hormone infusion.
    Gelato MC, Oldfield E, Loriaux DL, Merriam GR.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):585-90. PubMed ID: 2118536
    [Abstract] [Full Text] [Related]

  • 28. Plasma growth hormone response to growth hormone-releasing factor in acromegalic patients.
    Shibasaki T, Shizume K, Masuda A, Nakahara M, Hizuka N, Miyakawa M, Takano K, Demura H, Wakabayashi I, Ling N.
    J Clin Endocrinol Metab; 1984 Jan; 58(1):215-7. PubMed ID: 6417156
    [Abstract] [Full Text] [Related]

  • 29. Growth hormone secretion in anaesthetized fowl. 1. Refractoriness to repeated stimulation by human pancreatic growth hormone-releasing factor (hpGRF) or thyrotrophin releasing hormone (TRH).
    Harvey S, Scanes CG, Phillips JG.
    Gen Comp Endocrinol; 1985 Jul; 59(1):1-9. PubMed ID: 3926599
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Acromegaly due to a growth hormone-releasing hormone-secreting bronchial carcinoid tumor: further information on the abnormal responsiveness of the somatotroph cells and their recovery after successful treatment.
    Boizel R, Halimi S, Labat F, Cohen R, Bachelot I.
    J Clin Endocrinol Metab; 1987 Feb; 64(2):304-8. PubMed ID: 3098773
    [Abstract] [Full Text] [Related]

  • 32. Human pancreatic tumor GH-releasing factor.
    Thorner MO, Evans WS, Vance M, Borges JL, Blizzard RM, Rogol AD, MacLeod RM, Cronin MJ, Frohman LA, Thominet JL.
    Acta Neurochir (Wien); 1985 Feb; 75(1-4):72-80. PubMed ID: 2986423
    [Abstract] [Full Text] [Related]

  • 33. The effects of thyroid hormone deprivation in vivo and in vitro on growth hormone (GH) responses to human pancreatic (tumor) GH-releasing factor (1-40) by dispersed rat anterior pituitary cells.
    Dieguez C, Foord SM, Peters JR, Hall R, Scanlon MF.
    Endocrinology; 1985 Mar; 116(3):1066-70. PubMed ID: 3918846
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
    Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K.
    J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
    [Abstract] [Full Text] [Related]

  • 36. Growth hormone-releasing hormone infusion in patients with active acromegaly.
    Losa M, Chiodini PG, Liuzzi A, König A, Müller OA, Schopohl J, von Werder K.
    J Clin Endocrinol Metab; 1986 Jul; 63(1):88-93. PubMed ID: 3086362
    [Abstract] [Full Text] [Related]

  • 37. Stimulation of growth hormone by vasoactive intestinal polypeptide in acromegaly.
    Chihara K, Kaji H, Minamitani N, Kodama H, Kita T, Goto B, Chiba T, Coy DH, Fujita T.
    J Clin Endocrinol Metab; 1984 Jan; 58(1):81-6. PubMed ID: 6417157
    [Abstract] [Full Text] [Related]

  • 38. Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.
    Barkan AL, Kelch RP, Hopwood NJ, Beitins IZ.
    J Clin Endocrinol Metab; 1988 Jan; 66(1):16-23. PubMed ID: 2891720
    [Abstract] [Full Text] [Related]

  • 39. Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor.
    Wehrenberg WB, Brazeau P, Ling N, Textor G, Guillemin R.
    Endocrinology; 1984 May; 114(5):1613-6. PubMed ID: 6143658
    [Abstract] [Full Text] [Related]

  • 40. Glycoprotein hormone alpha-subunit response to growth hormone (GH)-releasing hormone in patients with active acromegaly. Evidence for alpha-subunit and GH coexistence in the same tumoral cell.
    Beck-Peccoz P, Bassetti M, Spada A, Medri G, Arosio M, Giannattasio G, Faglia G.
    J Clin Endocrinol Metab; 1985 Sep; 61(3):541-6. PubMed ID: 2410443
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.